======= COMMD3 ======= == Gene Information == * **Official Symbol**: COMMD3 * **Official Name**: COMM domain containing 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23412|23412]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBI1|Q9UBI1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616700|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (PubMed:23637203). {ECO:0000269|PubMed:15799966, ECO:0000269|PubMed:23637203, ECO:0000305|PubMed:21778237}. |HCaRG| |ficolin-1-rich granule lumen| |sodium ion transport| |monovalent inorganic cation transport| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |metal ion transport| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |cation transport| |leukocyte activation| |secretion by cell| |export from cell| |cell activation| |immune effector process| |secretion| |ion transport| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.72| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.54| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.16| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.1| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-2.08| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.7| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.79| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.87| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.01| ^Gene^Correlation^ |[[:human genes:c:commd5|COMMD5]]|0.613| |[[:human genes:v:vps29|VPS29]]|0.605| |[[:human genes:a:arpc4|ARPC4]]|0.588| |[[:human genes:c:ccdc22|CCDC22]]|0.588| |[[:human genes:a:actr3|ACTR3]]|0.581| |[[:human genes:a:arpc2|ARPC2]]|0.565| |[[:human genes:c:commd10|COMMD10]]|0.513| |[[:human genes:c:commd2|COMMD2]]|0.51| |[[:human genes:r:rab7a|RAB7A]]|0.499| |[[:human genes:a:actr2|ACTR2]]|0.49| |[[:human genes:c:commd9|COMMD9]]|0.489| |[[:human genes:k:kiaa0196|KIAA0196]]|0.48| |[[:human genes:c:commd7|COMMD7]]|0.478| |[[:human genes:v:vps35|VPS35]]|0.455| |[[:human genes:c:ccdc53|CCDC53]]|0.451| |[[:human genes:g:gpr107|GPR107]]|0.446| |[[:human genes:k:kiaa1033|KIAA1033]]|0.413| |[[:human genes:c:commd4|COMMD4]]|0.412| |[[:human genes:c:ccdc93|CCDC93]]|0.408| |[[:human genes:c:c16orf62|C16orf62]]|0.403| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6963 * **Expression level (log2 read counts)**: 5.58 {{:chemogenomics:nalm6 dist.png?nolink |}}